Romaric Loffroy

Prof. Romaric Loffroy

Department of Vascular Medicine and Interventional Radiology, Image-Guided Therapy Center, François-Mitterrand University Hospital
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2009 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
RLRomaric Loffroy
Romaric Loffroy
BGBoris Guiu
Boris Guiu
PDPhilippe D'AThis
Philippe D'AThis
LMLise Mezzetta
Lise Mezzetta
AGAlice Gagnaire
Alice Gagnaire
DKDenis Krausé
Denis Krausé

1 April 2009 in Current Vascular Pharmacology
Verified
Journal Article
Closed access
PDF file
RLRomaric Loffroy
Romaric Loffroy
BGBoris Guiu
Boris Guiu
JCJean-Pierre Cercueil
Jean-Pierre Cercueil
DKDenis Krause
Denis Krause
Vascular embolisation agents are particles or fluids that can be released into the bloodstream through a catheter to mechanically and/or biologically occlude the target vessel, either temporarily or permanently. This definition excludes vessel-blocking agents or devices such as balloons and coils, which are positioned at the target site, as opposed to released in the bloodstream. Vascular embolisation agents are available as solids, liquids and suspensions. Careful selection of the agent based on the size and calibre of the target vessel ensures that the occlusion is confined to the desired site. In this review, we discuss the 2 main categories of embolisation agents: particles (either non-spherical or microspherical), which are the most widely used; and liquids (glues, gels, sclerosing agents and viscous emulsions). For each agent, we review the characteristics, mechanisms of action, main indications and modalities of use, advantages and drawbacks. The use of embolisation in clinical practice requires a thorough understanding of the behaviour (rheology and vascular topology) and biocompatibility of each agent. To improve the accuracy of targeting, we need new, more sophisticated, bioactive agents, which are being developed.

1 July 2015 in Diagnostic and Interventional Imaging
Verified
Journal Article
Closed access
RLRomaric Loffroy
Romaric Loffroy
SFS. Favelier
S. Favelier
PPP. Pottecher
P. Pottecher
LEL. Estivalet
L. Estivalet
PGP.Y. Genson
P.Y. Genson
DKD. Krausé
D. Krausé

17 February 2011 in CardioVascular and Interventional Radiology
Verified
Journal Article
Closed access
RLRomaric Loffroy
Romaric Loffroy
MLMingDe Lin
MingDe Lin
PRPramod Rao
Pramod Rao
NBNikhil Bhagat
Nikhil Bhagat
NNNiels Noordhoek
Niels Noordhoek
JGJean-François Geschwind
Jean-François Geschwind

1 January 2009 in World Journal of Gastroenterology
Verified
Journal Article
Open access
RLRomaric Loffroy
Romaric Loffroy
BGBoris Guiu
Boris Guiu
Role of transcatheter arterial embolization for massive bleeding from gastroduodenal ulcers

1 July 2021 in Diagnostic and Interventional Imaging
Verified
Journal Article
Closed access
OCOlivier Chevallier
Olivier Chevallier
PCPierre-Olivier Comby
Pierre-Olivier Comby
KGKevin Guillen
Kevin Guillen
JPJulie Pellegrinelli
Julie Pellegrinelli
TMThomas Mouillot
Thomas Mouillot
RLRomaric Loffroy
Romaric Loffroy